GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avant Diagnostics Inc (GREY:AVDX) » Definitions » Interest Expense

Avant Diagnostics (Avant Diagnostics) Interest Expense : $-0.06 Mil (TTM As of Dec. 2018)


View and export this data going back to 2009. Start your Free Trial

What is Avant Diagnostics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Avant Diagnostics's interest expense for the three months ended in Dec. 2018 was $ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2018 was $-0.06 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Avant Diagnostics's Operating Income for the three months ended in Dec. 2018 was $ -0.52 Mil. Avant Diagnostics's Interest Expense for the three months ended in Dec. 2018 was $ -0.01 Mil. Avant Diagnostics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Avant Diagnostics Interest Expense Historical Data

The historical data trend for Avant Diagnostics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avant Diagnostics Interest Expense Chart

Avant Diagnostics Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Sep14 Sep15 Sep16 Sep17 Sep18
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.11 -0.70 -0.01

Avant Diagnostics Quarterly Data
Jan14 Apr14 Jul14 Oct14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.05 - - -0.01

Avant Diagnostics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avant Diagnostics  (GREY:AVDX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Avant Diagnostics's Interest Expense for the three months ended in Dec. 2018 was $-0.01 Mil. Its Operating Income for the three months ended in Dec. 2018 was $-0.52 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2018 was $0.00 Mil.

Avant Diagnostics's Interest Coverage for the quarter that ended in Dec. 2018 is calculated as

Avant Diagnostics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Avant Diagnostics (Avant Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
1050 30th Street NW, Suite 107, Washington, DC, USA, 20007
Avant Diagnostics Inc is a medical diagnostic technology company. Business activity of the group is functioned through United States. It focuses on the commercialization of a series of proprietary microarray-based diagnostic tests that provide early detection of cancers, neurodegenerative diseases, and other chronic and severe disease states. The company's premier product is OvaDx, a non-invasive proteomics diagnostic screening test for the early detection of ovarian cancer.